Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 135

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 4
Chunk 135
---
 on September 20, 2043.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising 3MMC and n-acylethanolamines for the treatment of dyskinesia: 1 pending application. The 20 year term for this family ends on July 26, 2044.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising MDMA and n-acylethanolamines uses thereof: 1 pending application. The 20 year term for this family ends on February 14, 2044.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Combinations of LSD and n-acylethanolamines: 1 pending application. The 20 year term for this family ends on February 9, 2044.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising of ketamine and n-acylethanolamines: 1 pending application. The 20 year term for this family ends on February 14, 2044.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising of ibogaine and n-acylethanolamines: 1 pending application. The 20 year term for this family ends on February 14, 2044.  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising of psilocybin and n-acylethanolamines: 1 pending application. The 20 year term for this family ends on February 9, 2044.  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Compositions comprising of DMT and n-acylethanolamines: 1 pending application. The 20 year term for this family ends on February 9, 2044.  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  MEAI for the treatment of depression: 1 pending application. The 20 year term for this family ends on March 22, 2044.  
 ─────────────────────────────────────────────────────────────────────────